生命科学公司Avantor, Inc. (AVTR) 今日盘前股价大幅下跌12.19%，引起了市场的广泛关注。
消息面上，公司公布了第四季度财报，其中调整后每股收益为22美分，符合分析师的平均预期；季度销售额达到16.6亿美元，略高于市场预期的16.4亿美元。然而，尽管财报数据达标，股价仍出现显著下滑。这可能反映了市场对公司长期前景的持续担忧，以及来自激进投资者的压力。去年，激进投资基金Engine Capital曾公开敦促公司更新董事会成员、削减成本，甚至考虑出售公司。
此外，公司的股价在2025年已经累计下跌了45%，此次盘前大跌可能是在此疲软趋势下的延续。市场参与者似乎更关注公司未来的战略方向和盈利能力改善的实质性进展，而非单季度的财务达标。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.